Ashland Completes Acquisition o...(ation may prove to be inaccurate and act...),Health

Date:11/13/2008

ation may prove to be inaccurate and actual results may differ significantly from those anticipated if one or more of the underlying assumptions or expectations proves to be inaccurate or is unrealized or if other unexpected conditions or events occur. Other factors, uncertainties and risks affecting Ashland are contained in Ashland's periodic filings made with the SEC, including its Form 10-K for the fiscal year ended Sept. 30, 2007, and Forms 10-Q for the quarters ended Dec. 31, 2007, and March 31 and June 30, 2008, which are available on Ashland's Investor Relations website at http//:www.ashland.com/investors or the SEC's website at http://www.sec.gov . Ashland undertakes no obligation to subsequently update or revise the forward-looking statements made in this news release to reflect events or circumstances after the date of this news release.

'/>"/>

SOURCE Ashland Inc. Copyright©2008 PR Newswire. All rights reserved

2 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Conseco Completes Transfer of Senior Health Insurance Company of Pennsylvania to Independent Trust
2. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
3. Cardium Completes $6.0 Million Financing
4. PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF
5. TomoTherapy Completes Acquisition of Linear Accelerator Manufacturer in China
6. Phyhealth Completes $250,000 Funding
7. Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
8. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
9. The RightThing Continues Drive: Completes Strong Q3
10. PreMD Inc. Completes Secured Debenture Financing
11. VA Suicide Prevention Panel Completes Draft Report